Krystal Biotech (KRYS) stock Forecast for 2021 – 2025

Krystal Biotech (KRYS) stock Forecast for 2022 – 2026

Last update: November 27, 2022 (05:55)

Sector: Healthcare

The share price of Krystal Biotech, Inc. (KRYS) now

What analysts predict: $104.75

52-week high/low: $102.99 / $38.86

50/200 Day Moving Average: $71.55 / $67.5

This figure corresponds to the average price over the previous 50/200 days. For Krystal Biotech stocks, the 50-day moving average is the support level today.

For Krystal Biotech stocks, the 200-day moving average is the support level today.

Are you interested in Krystal Biotech, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Krystal Biotech stock price in 2022, 2023, 2024, 2025, 2026. How much will one Krystal Biotech share be worth in 2022 - 2026?

When should I take profit in Krystal Biotech stock? When should I record a loss on Krystal Biotech stock? What are analysts' forecasts for Krystal Biotech stock? What is the future of Krystal Biotech stock? We forecast Krystal Biotech stock performance using neural networks based on historical data on Krystal Biotech stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Krystal Biotech stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Krystal Biotech shares. This happens once a day.




Historical and forecast chart of Krystal Biotech stock

The chart below shows the historical price of Krystal Biotech stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Krystal Biotech stock price can be found in the table below.

Long-term forecasts by years.

Krystal Biotech daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 29 80.68 79.13 81.88 3.47
Nov 30 79.33 77.46 80.53 3.97
Dec 01 76.76 75.99 77.99 2.63
Dec 02 77.34 75.86 79.01 4.16
Dec 03 76.91 76.08 79.31 4.25
Dec 04 77.43 75.85 78.76 3.84
Dec 05 77.59 75.26 78.52 4.33
Dec 06 76.25 74.06 77.53 4.70
Dec 07 77.38 76.14 78.84 3.54
Dec 08 74.90 73.89 76.37 3.37
Dec 09 74.72 73.77 75.71 2.63
Dec 10 74.78 73.02 75.38 3.24
Dec 11 76.31 74.05 77.41 4.53
Dec 12 76.07 74.30 76.74 3.28
Dec 13 75.88 75.15 77.83 3.55
Dec 14 76.95 74.51 78.12 4.83
Dec 15 78.70 77.13 80.43 4.29
Dec 16 80.46 78.56 82.39 4.88
Dec 17 79.79 79.05 80.62 1.98
Dec 18 77.39 76.28 78.91 3.45
Dec 19 76.15 74.05 77.34 4.44
Dec 20 76.43 75.36 77.07 2.27
Dec 21 76.70 74.40 78.36 5.32
Dec 22 78.79 77.75 80.05 2.96
Dec 23 77.47 75.67 78.83 4.18
Dec 24 76.26 74.15 78.42 5.76
Dec 25 75.68 74.17 77.28 4.20
Dec 26 76.89 75.01 78.80 5.04
Dec 27 77.81 76.41 79.87 4.52
Dec 28 77.25 75.18 78.67 4.64

Krystal Biotech Daily Price Targets


Krystal Biotech Stock Forecast 11-29-2022.

Forecast target price for 11-29-2022: $80.68.
Positive dynamics for Krystal Biotech shares will prevail with possible volatility of 3.350%.
Pessimistic target level: 79.13
Optimistic target level: 81.88

Krystal Biotech Stock Forecast 11-30-2022.

Forecast target price for 11-30-2022: $79.33.
Negative dynamics for Krystal Biotech shares will prevail with possible volatility of 3.822%.
Pessimistic target level: 77.46
Optimistic target level: 80.53

Krystal Biotech Stock Forecast 12-01-2022.

Forecast target price for 12-01-2022: $76.76.
Negative dynamics for Krystal Biotech shares will prevail with possible volatility of 2.559%.
Pessimistic target level: 75.99
Optimistic target level: 77.99

Krystal Biotech Stock Forecast 12-02-2022.

Forecast target price for 12-02-2022: $77.34.
Positive dynamics for Krystal Biotech shares will prevail with possible volatility of 3.994%.
Pessimistic target level: 75.86
Optimistic target level: 79.01

Krystal Biotech Stock Forecast 12-03-2022.

Forecast target price for 12-03-2022: $76.91.
Negative dynamics for Krystal Biotech shares will prevail with possible volatility of 4.073%.
Pessimistic target level: 76.08
Optimistic target level: 79.31

Krystal Biotech Stock Forecast 12-04-2022.

Forecast target price for 12-04-2022: $77.43.
Positive dynamics for Krystal Biotech shares will prevail with possible volatility of 3.697%.
Pessimistic target level: 75.85
Optimistic target level: 78.76

KRYS (KRYS) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 74.16 71.22 76.39 6.76

Krystal Biotech forecast for this year


Krystal Biotech Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $74.1605. Pessimistic: $71.22. Optimistic: $76.39



Krystal Biotech (KRYS) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 77.54 74.94 84.15 10.95
Feb 79.96 76.60 81.98 6.55
Mar 80.15 77.17 87.17 11.47
Apr 74.86 70.73 79.27 10.77
May 83.31 77.81 90.61 14.12
Jun 92.41 89.52 95.29 6.05
Jul 96.84 93.01 100.09 7.08
Aug 102.30 95.30 106.97 10.90
Sep 100.34 96.36 107.20 10.11
Oct 94.56 87.41 98.19 10.98
Nov 97.40 94.24 103.82 9.23
Dec 95.17 91.63 100.43 8.76

Krystal Biotech (KRYS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 106.60 99.69 114.40 12.86
Feb 113.50 107.37 124.13 13.50
Mar 116.64 108.38 123.77 12.44
Apr 125.87 122.10 133.58 8.59
May 133.43 126.38 138.39 8.68
Jun 127.50 121.23 131.94 8.12
Jul 130.26 126.04 134.32 6.17
Aug 123.69 114.64 132.75 13.64
Sep 118.35 113.38 125.16 9.42
Oct 125.45 117.02 131.17 10.79
Nov 138.85 130.35 143.51 9.17
Dec 135.68 124.45 140.57 11.47

Krystal Biotech (KRYS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 143.98 138.97 149.17 6.83
Feb 159.02 154.44 168.37 8.27
Mar 158.44 152.74 169.28 9.77
Apr 164.72 153.85 175.00 12.09
May 164.72 160.57 174.40 7.93
Jun 154.24 144.62 166.46 13.12
Jul 163.31 152.34 171.54 11.20
Aug 163.51 152.91 178.81 14.48
Sep 168.41 154.47 180.34 14.34
Oct 187.01 174.44 194.19 10.17
Nov 200.47 192.53 210.09 8.36
Dec 196.38 182.71 210.28 13.11

Krystal Biotech (KRYS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 213.82 207.92 221.26 6.03
Feb 223.31 211.79 240.20 11.83
Mar 215.81 200.27 223.84 10.53
Apr 226.69 213.90 241.10 11.28
May 236.21 224.59 246.98 9.07
Jun 243.29 231.62 254.39 8.95
Jul 245.34 236.50 268.89 12.04
Aug 264.18 239.45 288.91 17.12
Sep 261.33 245.96 276.38 11.01
Oct 269.79 251.66 281.45 10.58
Nov 289.54 264.87 316.29 16.26
Dec 301.70 274.19 330.30 16.99

Krystal Biotech information and performance

Krystal Biotech is a clinical gene therapy drug manufacturer committed to creating and marketing advanced therapies for skin patients. The company has developed and patented a gene therapy platform that enables the development of ready-to-use treatments for skin conditions that cannot be cured with known methods.

Krystal Biotech Address

2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, US

Market Capitalization: 1 992 092 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -105 651 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -4.478

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -12.62

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 25747600

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.